by palligoelme@gmail.com | Oct 15, 2026 | Clinical Trials
Conditions: Colonrectal Cancer; Colonrectal Cancer (CRC) Interventions: Behavioral: Compassionate Access Targeted Therapy Sponsors: Esbjerg Hospital – University Hospital of Southern Denmark Completed Conditions: Colonrectal Cancer; Colonrectal Cancer (CRC)...
by palligoelme@gmail.com | Oct 15, 2026 | Clinical Trials
Conditions: Idiopathic Pulmonary Fibrosis Interventions: Drug: CHF10073 low dose; Drug: CHF10073 high dose; Drug: Placebo Sponsors: Chiesi Farmaceutici S.p.A. Not yet recruiting Conditions: Idiopathic Pulmonary Fibrosis Interventions: Drug: CHF10073 low dose; Drug:...
by palligoelme@gmail.com | Oct 15, 2026 | Clinical Trials
Conditions: Health Communication; Patient Discharge Interventions: Other: Conventional Discharge Documentation Workflow; Other: LLM-Assisted Discharge Documentation Workflow Sponsors: University Hospital, Montpellier Completed Conditions: Health Communication;...
by palligoelme@gmail.com | Oct 15, 2026 | Clinical Trials
Conditions: Muscle-Invasive Bladder Cancer (MIBC) Interventions: Drug: Durvalumab; Drug: Gemcitabine; Drug: Cisplatin Sponsors: AstraZeneca Not yet recruiting Conditions: Muscle-Invasive Bladder Cancer (MIBC) Interventions: Drug: Durvalumab; Drug: Gemcitabine; Drug:...
by palligoelme@gmail.com | Oct 15, 2026 | Clinical Trials
Conditions: Breast Augmentation Interventions: Device: An injectable, biodegradable hydrogel, in reconstitution medium; Device: Reconstitution medium Sponsors: 4Tissue; Xper Research Recruiting Conditions: Breast Augmentation Interventions: Device: An injectable,...